These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 21674766)
1. Thirty-day readmission rates following hospitalization for pediatric sickle cell crisis at freestanding children's hospitals: risk factors and hospital variation. Sobota A; Graham DA; Neufeld EJ; Heeney MM Pediatr Blood Cancer; 2012 Jan; 58(1):61-5. PubMed ID: 21674766 [TBL] [Abstract][Full Text] [Related]
2. Clinical redesign using all patient refined diagnosis related groups. Sedman AB; Bahl V; Bunting E; Bandy K; Jones S; Nasr SZ; Schulz K; Campbell DA Pediatrics; 2004 Oct; 114(4):965-9. PubMed ID: 15466092 [TBL] [Abstract][Full Text] [Related]
3. Pediatric readmission prevalence and variability across hospitals. Berry JG; Toomey SL; Zaslavsky AM; Jha AK; Nakamura MM; Klein DJ; Feng JY; Shulman S; Chiang VW; Kaplan W; Hall M; Schuster MA JAMA; 2013 Jan; 309(4):372-80. PubMed ID: 23340639 [TBL] [Abstract][Full Text] [Related]
4. Corticosteroids for acute chest syndrome in children with sickle cell disease: variation in use and association with length of stay and readmission. Sobota A; Graham DA; Heeney MM; Neufeld EJ Am J Hematol; 2010 Jan; 85(1):24-8. PubMed ID: 19957348 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology of pediatric hospitalizations at general hospitals and freestanding children's hospitals in the United States. Leyenaar JK; Ralston SL; Shieh MS; Pekow PS; Mangione-Smith R; Lindenauer PK J Hosp Med; 2016 Nov; 11(11):743-749. PubMed ID: 27373782 [TBL] [Abstract][Full Text] [Related]
6. Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease. Strouse JJ; Takemoto CM; Keefer JR; Kato GJ; Casella JF Pediatr Blood Cancer; 2008 May; 50(5):1006-12. PubMed ID: 17849474 [TBL] [Abstract][Full Text] [Related]
7. Variation in Condition-Specific Readmission Rates Across US Children's Hospitals. Gay JC; Teufel RJ; Peltz A; Auger KA; Harris JM; Hall M; Neuman MI; Simon HK; Morse R; Eghtesady P; McClead R; Shah SS Acad Pediatr; 2022 Jul; 22(5):797-805. PubMed ID: 35081468 [TBL] [Abstract][Full Text] [Related]
8. Hospital Observation Status and Readmission Rates. Synhorst DC; Hall M; Harris M; Gay JC; Peltz A; Auger KA; Teufel RJ; Macy ML; Neuman MI; Simon HK; Shah SS; Lutmer J; Eghtesady P; Pavuluri P; Morse RB Pediatrics; 2020 Nov; 146(5):. PubMed ID: 33067343 [TBL] [Abstract][Full Text] [Related]
9. Risk factors for hospital readmission within 30 days: a new quality measure for children with sickle cell disease. Frei-Jones MJ; Field JJ; DeBaun MR Pediatr Blood Cancer; 2009 Apr; 52(4):481-5. PubMed ID: 19058209 [TBL] [Abstract][Full Text] [Related]
10. Epidemiology and Predictors of all-cause 30-Day readmission in patients with sickle cell crisis. Kumar V; Chaudhary N; Achebe MM Sci Rep; 2020 Feb; 10(1):2082. PubMed ID: 32034210 [TBL] [Abstract][Full Text] [Related]
11. Impact of individualized pain plan on the emergency management of children with sickle cell disease. Krishnamurti L; Smith-Packard B; Gupta A; Campbell M; Gunawardena S; Saladino R Pediatr Blood Cancer; 2014 Oct; 61(10):1747-53. PubMed ID: 24962217 [TBL] [Abstract][Full Text] [Related]
12. Variation in resource use and readmission for diabetic ketoacidosis in children's hospitals. Tieder JS; McLeod L; Keren R; Luan X; Localio R; Mahant S; Malik F; Shah SS; Wilson KM; Srivastava R; Pediatrics; 2013 Aug; 132(2):229-36. PubMed ID: 23878044 [TBL] [Abstract][Full Text] [Related]
13. Association of hospital and provider types on sickle cell disease outcomes. Jan S; Slap G; Smith-Whitley K; Dai D; Keren R; Rubin DM Pediatrics; 2013 Nov; 132(5):854-61. PubMed ID: 24167173 [TBL] [Abstract][Full Text] [Related]
14. Mortality During Readmission Among Children in United States Children's Hospitals. Rees CA; Neuman MI; Monuteaux MC; Michelson KA; Duggan CP J Pediatr; 2022 Jul; 246():161-169.e7. PubMed ID: 35364094 [TBL] [Abstract][Full Text] [Related]
15. Hospital readmission after management of appendicitis at freestanding children's hospitals: contemporary trends and financial implications. Rice-Townsend S; Hall M; Barnes JN; Baxter JK; Rangel SJ J Pediatr Surg; 2012 Jun; 47(6):1170-6. PubMed ID: 22703789 [TBL] [Abstract][Full Text] [Related]
16. Clinical and Geographic Characterization of 30-Day Readmissions in Pediatric Sickle Cell Crisis Patients. McMillan JE; Meier ER; Winer JC; Coco M; Daymont M; Long S; Jacobs BR Hosp Pediatr; 2015 Aug; 5(8):423-31. PubMed ID: 26231632 [TBL] [Abstract][Full Text] [Related]
17. Association of Weekend Admission and Weekend Discharge with Length of Stay and 30-Day Readmission in Children's Hospitals. Markham JL; Richardson T; Hall M; Bonafide CP; Williams DJ; Auger KA; Wilson KM; Shah SS; J Hosp Med; 2019 Feb; 14(2):75-82. PubMed ID: 30379138 [TBL] [Abstract][Full Text] [Related]
18. Association of Antibiotic Choice With Hospital Length of Stay and Risk Factors for Readmission in Patients With Sickle Cell Disease and Acute Chest Syndrome: An Observational Cohort Study. Badaki-Makun O; Casella JF; Tackett S; Tao X; Chamberlain JM Ann Emerg Med; 2020 Sep; 76(3S):S37-S45. PubMed ID: 32928460 [TBL] [Abstract][Full Text] [Related]
19. Variation in hospital admission of sickle cell patients from the emergency department using the Pediatric Health Information System. Jacob SA; Mueller EL; Cochrane AR; Carroll AE; Bennett WE Pediatr Blood Cancer; 2020 Jun; 67(6):e28067. PubMed ID: 31724788 [TBL] [Abstract][Full Text] [Related]